Some State Licensing Approaches Can Fuel the Illicit Cannabis Market
As long as cannabis remains federally illegal and licensing remains the responsibility of states, each state may continue to act based on their own estimation of the trade-offs involved, which can carry negative externalities for other.
Canadian Company Requests Approval To Manufacture MDMA, Other Synthetic Psychedelics
The move would enable the Company to synthesize, process and distribute pharmaceutical grade 3,4-Methylenedioxymethamphetamine (“MDMA”), among other substances, at its Princeton, British Columbia facility.
European CBD Company Reacts to the EFSA’s Decision to Halt Novel Foods Process
Susanne Caspar, CEO of Linnea, a Switzerland-based CBD company, tells Analytical Cannabis what comes next after the EFSA's recent decision.
Aurum Labs Becomes the First Independent Hemp Lab to Be Certified for New Pesticide Tests
The lab is now certified to test hemp samples for 102 pesticides – the most expansive hemp pesticide list in the US.
Current Evidence Does Not Support Use of Cannabis in Palliative Care, Review Finds
A new review published in the Journal of Pain and Symptom Management has concluded that while positive treatment effects have been reported for some medical cannabis formulations, there are significant quality problems with current evidence.
Mystical Psilocybin Trips Linked to Lasting Positive Psychological Effects, Study Finds
New research published in the journal Frontiers in Pharmacology has found that the mystical experiences induced by psilocybin are closely linked to long-lasting positive psychological effects in healthy individuals.
Project Twenty21 Publishes First Observations on Chronic Pain
A second paper is scheduled to be published later in 2022 which will examine the effect of medical cannabis treatment on these patients at the three- and six-month follow-up appointments.
Oregon Bans Synthetic Cannabis
Oregon is set to become the first US state to ban the sale of synthetic cannabinoid products.
European Food Standards Agency Halts CBD Novel Foods Applications
Before the announcement, the European agency had been processing 19 applications for CBD products, all of which are now in limbo.
